Auricle Analysis: $35M Raised
What is Auricle?
Auricle develops a neurostimulation implant aimed at restoring hearing for patients who cannot benefit from traditional hearing aids.
Employees
2
Founded
2020
Revenue
$7.9M
Product Features & Capabilities
- neurostimulation implant for hearing restoration, designed for patients with severe hearing loss, minimally invasive approach, preserves residual hearing, targets high-frequency hearing loss, reversible implantation process
How much Auricle raised
Funding Round - $35 million
July 2023Lead Investor: Microsoft M12 and other top US and European investors.
Who are the founders of Auricle
FW
Francis Wong
Founder
JD
Jay Dhuldhoya
Founder
Market Focus
Auricle primarily focuses on the medical device industry, specifically developing neurostimulation implants aimed at restoring hearing for patients who do not benefit from traditional hearing aids.
Competitors Overview
Auricle operates in the medical device market focused on hearing restoration through neurostimulation implants. Its main competitors include:
- Cochlear Limited: A leading company in cochlear implant technology, Cochlear Limited offers devices that provide a sense of sound to individuals with
Investors
- Y Combinator
- North South Ventures
- Digilife
- Fogarty Innovation
See something that needs updating? Suggest edits to this profile.